Pure Biologics S.A. (WSE:PUR)

Poland flag Poland · Delayed Price · Currency is PLN
4.132
-1.263 (-23.41%)
Jun 27, 2025, 4:45 PM CET
-50.51%
Market Cap 22.02M
Revenue (ttm) n/a
Net Income (ttm) -15.80M
Shares Out 4.08M
EPS (ttm) -4.34
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 315,477
Average Volume 91,902
Open 3.720
Previous Close 5.400
Day's Range 3.720 - 4.500
52-Week Range 4.060 - 33.200
Beta 1.27
RSI 38.28
Earnings Date Sep 9, 2025

About Pure Biologics

Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified apta... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 7
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.